585 related articles for article (PubMed ID: 7544433)
1. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
[TBL] [Abstract][Full Text] [Related]
2. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
3. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a Ca(2+)-(*)NO-cGMP signaling pathway controlling zoospore biogenesis in the aquatic fungus Blastocladiella emersonii.
Vieira AL; Linares E; Augusto O; Gomes SL
Fungal Genet Biol; 2009 Aug; 46(8):575-84. PubMed ID: 19393757
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
Bunton D; MacDonald A; Brown T; Tracey A; McGrath JC; Shaw AM
Clin Sci (Lond); 2000 Jan; 98(1):81-9. PubMed ID: 10600662
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
8. Burn-induced lung damage in rat is mediated by a nitric oxide/cGMP system.
Chen LW; Hwang YC; Chen CJ; Wang JS; Chen JS; Hsu CM
Shock; 2003 Oct; 20(4):369-74. PubMed ID: 14501952
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
Fragata IR; Ribeiro JA; Sebastião AM
Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
[TBL] [Abstract][Full Text] [Related]
10. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
11. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
12. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
14. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
15. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
Persson AA; Gunnarsson P; Lindström E; Grenegård M
Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
[TBL] [Abstract][Full Text] [Related]
16. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
17. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release.
Fedele E; Varnier G; Ansaldo MA; Raiteri M
Br J Pharmacol; 1998 Nov; 125(5):1042-8. PubMed ID: 9846643
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
Hanke CJ; Drewett JG; Myers CR; Campbell WB
Endocrinology; 1998 Oct; 139(10):4053-60. PubMed ID: 9751482
[TBL] [Abstract][Full Text] [Related]
19. Cardiac mitochondrial cGMP stimulates cytochrome c release.
Seya K; Motomura S; Furukawa K
Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461
[TBL] [Abstract][Full Text] [Related]
20. Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria.
Herring N; Golding S; Paterson DJ
J Mol Cell Cardiol; 2000 Oct; 32(10):1795-804. PubMed ID: 11013124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]